<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Mycobacterium ulcerans &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/mycobacterium-ulcerans/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Fri, 09 Oct 2026 06:28:00 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.3</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Mycobacterium ulcerans &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Shorter High-Dose Antibiotic Course for Buruli Ulcer Shows Promise but Falls Short in Ghana Trial</title>
		<link>https://bioengineer.org/shorter-high-dose-antibiotic-course-for-buruli-ulcer-shows-promise-but-falls-short-in-ghana-trial/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Fri, 09 Oct 2026 06:28:00 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[antibiotic therapy]]></category>
		<category><![CDATA[Buruli ulcer]]></category>
		<category><![CDATA[clarithromycin]]></category>
		<category><![CDATA[clinical trial]]></category>
		<category><![CDATA[Ghana]]></category>
		<category><![CDATA[microbiological clearance]]></category>
		<category><![CDATA[Mycobacterium ulcerans]]></category>
		<category><![CDATA[neglected tropical diseases]]></category>
		<category><![CDATA[paradoxical reactions]]></category>
		<category><![CDATA[PLOS Neglected Tropical Diseases]]></category>
		<category><![CDATA[randomized controlled trial]]></category>
		<category><![CDATA[rifampicin]]></category>
		<guid isPermaLink="false">https://bioengineer.org/?p=409663</guid>

					<description><![CDATA[A Ghanaian randomized trial found that a four-week high-dose rifampicin and clarithromycin regimen was well tolerated for Buruli ulcer but did not significantly shorten microbiological clearance compared with the standard eight-week course.]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">409663</post-id>	</item>
	</channel>
</rss>
